These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23300160)

  • 1. Combined effects of antenatal receipt of influenza vaccine by mothers and pneumococcal conjugate vaccine receipt by infants: results from a randomized, blinded, controlled trial.
    Omer SB; Zaman K; Roy E; Arifeen SE; Raqib R; Noory L; Seib K; Breiman RF; Steinhoff MC
    J Infect Dis; 2013 Apr; 207(7):1144-7. PubMed ID: 23300160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of pneumococcal conjugate vaccine in infants by maternal influenza vaccination status.
    van Santen KL; Bednarczyk RA; Adjaye-Gbewonyo D; Orenstein WA; Davis R; Omer SB
    Pediatr Infect Dis J; 2013 Nov; 32(11):1180-4. PubMed ID: 23856786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled trial.
    Jansen AG; Sanders EA; Hoes AW; van Loon AM; Hak E
    J Pediatr; 2008 Dec; 153(6):764-70. PubMed ID: 18621393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.
    Adam D; Fehnle K
    Vaccine; 2008 Nov; 26(47):5944-51. PubMed ID: 18801402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the prevention of respiratory infections and management in children (PRIMAKid) study: a randomized controlled trial on the effectiveness and costs of combined influenza and pneumococcal vaccination in pre-school children with recurrent respiratory tract infections.
    Schönbeck Y; Sanders EA; Hoes AW; Schilder AG; Verheij TJ; Hak E
    Vaccine; 2005 Sep; 23(41):4906-14. PubMed ID: 16005552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada.
    Vanderkooi OG; Scheifele DW; Girgenti D; Halperin SA; Patterson SD; Gruber WC; Emini EA; Scott DA; Kellner JD;
    Pediatr Infect Dis J; 2012 Jan; 31(1):72-7. PubMed ID: 21960186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of maternal influenza immunization in mothers and infants.
    Zaman K; Roy E; Arifeen SE; Rahman M; Raqib R; Wilson E; Omer SB; Shahid NS; Breiman RF; Steinhoff MC
    N Engl J Med; 2008 Oct; 359(15):1555-64. PubMed ID: 18799552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.
    Klugman KP; Madhi SA; Huebner RE; Kohberger R; Mbelle N; Pierce N;
    N Engl J Med; 2003 Oct; 349(14):1341-8. PubMed ID: 14523142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.
    Tse A; Tseng HF; Greene SK; Vellozzi C; Lee GM;
    Vaccine; 2012 Mar; 30(11):2024-31. PubMed ID: 22361304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza season triggers pneumococcal vaccination.
    Goebel LJ; Mufson MA
    J Am Geriatr Soc; 2006 Aug; 54(8):1261-4. PubMed ID: 16913996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years.
    Schwarz TF; Flamaing J; Rümke HC; Penzes J; Juergens C; Wenz A; Jayawardene D; Giardina P; Emini EA; Gruber WC; Schmoele-Thoma B
    Vaccine; 2011 Jul; 29(32):5195-202. PubMed ID: 21619909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants.
    Black SB; Shinefield HR; France EK; Fireman BH; Platt ST; Shay D;
    Am J Perinatol; 2004 Aug; 21(6):333-9. PubMed ID: 15311370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study.
    Englund JA; Walter E; Black S; Blatter M; Nyberg J; Ruben FL; Decker MD;
    Pediatr Infect Dis J; 2010 Feb; 29(2):105-10. PubMed ID: 19934787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
    Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
    Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oil-in-water emulsion adjuvant with influenza vaccine in young children.
    Vesikari T; Knuf M; Wutzler P; Karvonen A; Kieninger-Baum D; Schmitt HJ; Baehner F; Borkowski A; Tsai TF; Clemens R
    N Engl J Med; 2011 Oct; 365(15):1406-16. PubMed ID: 21995388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designs of two randomized, community-based trials to assess the impact of influenza immunization during pregnancy on respiratory illness among pregnant women and their infants and reproductive outcomes in rural Nepal.
    Tielsch JM; Steinhoff M; Katz J; Englund JA; Kuypers J; Khatry SK; Shrestha L; LeClerq SC
    BMC Pregnancy Childbirth; 2015 Feb; 15():40. PubMed ID: 25879974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreasing invasive pneumococcal disease in the elderly: a state-level analysis.
    McBean AM; Jung K; Hebert PL
    Vaccine; 2006 Jul; 24(27-28):5609-14. PubMed ID: 16725240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants.
    Prescrire Int; 2006 Dec; 15(86):227-33. PubMed ID: 17167934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of pneumococcal disease prevention.
    Rodgers GL; Klugman KP
    Vaccine; 2011 Sep; 29 Suppl 3():C43-8. PubMed ID: 21896352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine.
    Stockwell MS; Broder K; LaRussa P; Lewis P; Fernandez N; Sharma D; Barrett A; Sosa J; Vellozzi C
    JAMA Pediatr; 2014 Mar; 168(3):211-9. PubMed ID: 24395025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.